Donna L Berry1, Manan Nayak1, Barbara Halpenny1, Shannon Harrington1, Kevin R Loughlin2, Peter Chang3, Jonathan E Rosenberg4, Adam S Kibel2. 1. The Phyllis F. Cantor Center, Dana-Farber Cancer Institute, Boston, MA, USA. 2. Division of Urologic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. 3. Division of Urologic Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA. 4. Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Abstract
Background: Each stage of bladder cancer involves varying treatment issues and concerns that are discussed between patients and providers during the pre-treatment consultation. There is no documentation of how patients engage in decision making. Objective: To describe aspects of treatment decision making perceived by patients with bladder cancer using qualitative analysis of data from individual interviews. Methods: Patients with any stage bladder cancer were recruited from urology and medical oncology services at a comprehensive cancer center. A qualitative approach to data collection and analysis was applied. Individual, semi-structured interviews were conducted, recorded and transcribed. Coding of the transcripts was conducted by research team members, discussed for consensus and major themes derived. Results: 45 men and 15 women, the majority college educated, were recruited. Where to receive care, including from whom, was the initial and major decision. Challenges of decisions regarding urinary reconstruction were dominant. Personal characteristics, including age and being active, were considered. Participants with early stage tumors (n = 28) typically perceived only one treatment option and followed the physician's recommendation. The 18 participants with stage II-III were aware of multiple options. In 14 stage IV participants, balancing quality of life and outcomes between treatments was common to the decision process. Conclusions: For this educated sample with bladder cancer, recruited at a comprehensive cancer center, the major decision was to seek treatment at a location with the highest level of physician expertise. Personal preferences informed decisions surrounding bladder reconstruction. Further research will be conducted in a diverse sample of patients making decisions in a non-urban, community setting.
Background: Each stage of bladder cancer involves varying treatment issues and concerns that are discussed between patients and providers during the pre-treatment consultation. There is no documentation of how patients engage in decision making. Objective: To describe aspects of treatment decision making perceived by patients with bladder cancer using qualitative analysis of data from individual interviews. Methods:Patients with any stage bladder cancer were recruited from urology and medical oncology services at a comprehensive cancer center. A qualitative approach to data collection and analysis was applied. Individual, semi-structured interviews were conducted, recorded and transcribed. Coding of the transcripts was conducted by research team members, discussed for consensus and major themes derived. Results: 45 men and 15 women, the majority college educated, were recruited. Where to receive care, including from whom, was the initial and major decision. Challenges of decisions regarding urinary reconstruction were dominant. Personal characteristics, including age and being active, were considered. Participants with early stage tumors (n = 28) typically perceived only one treatment option and followed the physician's recommendation. The 18 participants with stage II-III were aware of multiple options. In 14 stage IV participants, balancing quality of life and outcomes between treatments was common to the decision process. Conclusions: For this educated sample with bladder cancer, recruited at a comprehensive cancer center, the major decision was to seek treatment at a location with the highest level of physician expertise. Personal preferences informed decisions surrounding bladder reconstruction. Further research will be conducted in a diverse sample of patients making decisions in a non-urban, community setting.
Entities:
Keywords:
Bladder cancer; qualitative evaluation; shared decision making
Authors: Shoshana M Rosenberg; Karen Sepucha; Kathryn J Ruddy; Rulla M Tamimi; Shari Gelber; Meghan E Meyer; Lidia Schapira; Steven E Come; Virginia F Borges; Mehra Golshan; Eric P Winer; Ann H Partridge Journal: Ann Surg Oncol Date: 2015-05-01 Impact factor: 5.344
Authors: Martine T E Puts; Brianne Tapscott; Margaret Fitch; Doris Howell; Johanne Monette; Doreen Wan-Chow-Wah; Monika Krzyzanowska; Nathasha B Leighl; Elena Springall; Shabbir M Alibhai Journal: Cancer Treat Rev Date: 2014-12-26 Impact factor: 12.111
Authors: Jane C Weeks; Paul J Catalano; Angel Cronin; Matthew D Finkelman; Jennifer W Mack; Nancy L Keating; Deborah Schrag Journal: N Engl J Med Date: 2012-10-25 Impact factor: 91.245
Authors: Donna L Berry; William J Ellis; Nancy Fugate Woods; Christina Schwien; Kristin H Mullen; Claire Yang Journal: Urol Oncol Date: 2003 Mar-Apr Impact factor: 3.498
Authors: Aileen B Chen; Angel Cronin; Jane C Weeks; Elizabeth A Chrischilles; Jennifer Malin; James A Hayman; Deborah Schrag Journal: J Clin Oncol Date: 2013-06-17 Impact factor: 44.544
Authors: Nihal Mohamed; Tung Ming Leung; Qainat N Shah; Sailaja Pisipati; Donna L Berry; Emma K T Benn; Cheryl T Lee; Simon Hall; Reza Mehrazin; John Sfakianos Journal: J Cancer Educ Date: 2020-08 Impact factor: 2.037
Authors: Matthew D Galsky; Michael Diefenbach; Nihal Mohamed; Charles Baker; Sumit Pokhriya; Jason Rogers; Ashish Atreja; Liangyuan Hu; Che-Kai Tsao; John Sfakianos; Reza Mehrazin; Nikhil Waingankar; William K Oh; Madhu Mazumdar; Bart S Ferket Journal: JCO Clin Cancer Inform Date: 2017-11
Authors: Carmit K McMullen; Marilyn L Kwan; Janice C Colwell; Julie R Munneke; James V Davis; Alison Firemark; Neon Brooks; Marcia Grant; Scott M Gilbert; Andrea Altschuler Journal: Bladder Cancer Date: 2019-01-31
Authors: Jiil Chung; Girish S Kulkarni; Robin Morash; Andrew Matthew; Janet Papadakos; Rodney H Breau; David Guttman; Jackie Bender; Jennifer M Jones Journal: Support Care Cancer Date: 2019-02-14 Impact factor: 3.603